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Glomerulonephritis (GN) due to infective endocarditis (IE) is
well documented, but most available data are based on old
autopsy series. To update information, we now present the
largest biopsy-based clinicopathologic series on IE-associated
GN. The study group included 49 patients (male-to-female
ratio of 3.5:1) with a mean age of 48 years. The most common
presenting feature was acute kidney injury. Over half of the
patients had no known prior cardiac abnormality. However,
the most common comorbidities were cardiac valve disease
(30%), intravenous drug use (29%), hepatitis C (20%), and
diabetes (18%). The cardiac valve infected was tricuspid in
43%, mitral in 33%, and aortic in 29% of patients. The two
most common infective bacteria were Staphylococcus (53%)
and Streptococcus (23%). Hypocomplementemia was found in
56% of patients tested and ANCA antibody in 28%. The most
common biopsy finding was necrotizing and crescentic GN
(53%), followed by endocapillary proliferative GN (37%).
C3 deposition was prominent in all cases, whereas IgG
deposition was seen in o30% of cases. Most patients had
immune deposits detectable by electron microscopy. Thus,
IE-associated GN most commonly presents with AKI and
complicates staphylococcal tricuspid valve infection. Contrary
to infection-associated glomerulonephritis in general, the
most common pattern of glomerular injury in IE-associated
glomerulonephritis was necrotizing and crescentic
glomerulonephritis.
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Renal disease due to infective endocarditis (IE) is well
established, with the earliest reports of glomerular lesions
published over 100 years ago.1–3 Although initially believed to
be primarily embolic,1–3 it later became clear that over 80%
of cases represented focal, segmental, or diffuse proliferative
glomerulonephritis (GN) with prominent endocapillary
proliferation and occasional infiltrating leukocytes.4–6
However, the literature describing nephritis associated with
IE still relies heavily on autopsy studies conducted in the pre-
and early postantibiotic era or small renal biopsy studies
from the 1970s.
Several reviews have emphasized the evolution occurring
in recent decades in renal complications of infectious diseases
in general, with particular emphasis on the change in
demographics from younger to older patients, the frequency
of comorbidities such as diabetes and HIV, and the change in
predominance of infectious agents from primarily strepto-
coccal to a broader array of organisms with predominance of
Staphylococci.7–10
IE occurs in 30 to 60% of patients with Staphylococcus
aureus bacteremia and carries a mortality rate of 40–50%.11
Over the past decades, IE outcomes have not improved, and
infection rates are steadily increasing.11 Recent case series
and reviews of IE have compared findings from current
and previous eras, confirmed similar changes in the
demographics of the disease, and updated the clinical and
pathologic features in both adults and children.5,12 However,
few of these recent reports have focused primarily on IE-
related renal lesions, and much of the data currently available
still include predominately autopsy-derived information.5,13
Based on all of the above, we investigated the clinico-
pathologic characteristics of a large cohort of patients with
IE-associated GN diagnosed by kidney biopsy between 2001
and 2011 in two large nephropathology laboratories. Our
data indicate that IE-associated GN in the new era has
significantly different clinical and pathologic changes from
those described historically.
RESULTS
Clinical features
The clinical characteristics of 49 patients undergoing a renal
biopsy with documented IE are detailed in Table 1. Features
of note include a male predominance (3.5:1) with a mean age
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at biopsy of 48 years. Two patients (4%) were children o18
years, and 30% of patients were elderly (Z60 years of age).
Acute renal failure was the most common presenting
condition (79%), with hematuria present in almost all cases
(97%), yet typical acute nephritic syndrome in onlyo10% of
cases. Conditions favoring endocarditis were noted in 29
patients including intravenous drug use (29%), prosthetic
valves (18%), and prior valvular disease (12%). However,
over 50% of patients did not have known prior cardiac
disease. Associated comorbid conditions were noted in a
minority of patients, the most common being hepatitis C
infection (20%) and diabetes mellitus (18%) (Table 1).
Serologic studies
Serologic studies are summarized in Table 1. While 53% of
the 32 patients tested for serum complement had reduced C3
(complement component 3) levels only a minority of patients
(19%) in whom it was tested had reductions in C4,
suggesting that most had activation of the alternative
complement pathway. Anti-neutrophil cytoplasmic antibody
(ANCA) data was obtained in 43/49 patients (88%), although
testing was not carried out in 14/43 patients. Of the 29/43
patients with ANCA serologies drawn, 21 were negative
(72%) and 8 were positive (28%). ANCA specificities of these
8 patients include 3 pANCA (one with positive MPO), 3
cANCA (two with positive PR3), 1 positive ANCA of
unspecified type, and 1 with dual-positive MPO and PR3.
Anti-nuclear antibody (ANA) was positive in 4/26 patients
tested (15%). One patient with a positive ANA had history of
systemic lupus erythematosus (SLE), although renal biopsy
was without significant immune complex (IC) deposition. In
the other three patients, the positive ANA was an isolated
finding, with none having clinical evidence of SLE.
Cardiac involvement
Details of the IE are shown in Table 2. Cardiac infections
most commonly involved the tricuspid valve (43%), followed
by the mitral (33%), aortic (29%), and pulmonic (5%)
valves. Five patients (12%) had involvement of two cardiac
valves. One patient with tricuspid valve endocarditis also had
a ventricular atrial shunt infection. Echocardiogram vegeta-
tions were noted in greater than two-thirds of patients. The
most commonly noted sign of cardiac involvement in
patients without vegetations on echocardiogram was new
valvular regurgitation/murmur; the most common other
criteria for diagnosis of IE in these patients included fever,
septic pulmonary emboli, and predisposing heart condition
or injection drug use. The most common vascular phenom-
ena in the entire cohort was septic pulmonary infarcts, with
only a minority of patients with intracranial hemorrhage, and
rare patients with conjunctival hemorrhages, nail splinter
hemorrhages, or evidence of mycotic aneurysm.
Infectious agents
The most common infectious agent found on blood culture
was S. aureus (53%), with methicillin resistance in 56%
(Table 2). Streptococcus species were the second most
common pathogens found (23%). Less common causes of
endocarditis were Bartonella henselae in four patients,
Coxiella burnetii in two, Cardiobacterium hominis in one,
and Gemella species in one. Four patients (9%) had culture-
negative endocarditis, similar to findings in other series.14,15
Staphylococcal infection was the most common cause of
endocarditis in patients with a history of intravenous drug
abuse (77%), with the tricuspid valve or tricuspid and
pulmonic valves (in one patient) affected in 83% and mitral
or aortic valves in 17%. There were no significant
associations noted between individual bacteria and the light
microscopic appearance of GN, except that 6/7 cases with
Table 1 |Demographics and clinical characteristics
Gender/age
Male:female, n/n (%/%) 38/11 (78/22)
Age (years), mean (range) 48 (3–84)
n (%)
Clinical syndrome n¼ 47 with data (%)
Acute renal failure 37 (79)
Acute nephritic syndrome 4 (9)
Rapidly progressive glomerulonephritis 3 (6)
Nephrotic syndrome 3 (6)
Predisposing statesa
Intravenous drug abuse 14 (29)
Prosthetic cardiac valve 9 (18)
Cardiac valve disease/Intracardiac shunt 6 (12)
Associated conditions
Hepatitis C 10 (20)
Diabetes mellitus 9 (18)
Coronary artery disease 3 (6)
Chronic obstructive pulmonary disease 2 (4)
Congestive heart failure 1 (2)
Systemic lupus erythematosus 1 (2)
Recent surgery 1 (2)
Prostate cancer 1 (2)
Median (range)
Laboratory data
Serum creatinine at biopsy (mg/dl), n¼ 45 3.8 (1.0–12.0)
Proteinuria (g per day), n¼ 18 1.8 (0.5–15)
n (%)
Hematuria, n¼ 37 36 (97)
ANA, n¼ 26
Positive 4 (15)
ANCA, n¼ 29b
Positive 8 (28)
C3/C4, n¼ 32
Low C3 only 12 (37)
Low C4 only 1 (3)
Low C3 and C4 5 (16)
Normal C3 and C4 14 (44)
Abbreviations: ANA, anti-nuclear antibody; ANCA, anti-neutrophil cytoplasmic
antibody; C3, complement component 3; C4, complement component.
aOne patient with a prosthetic valve and one patient with tricuspid insufficiency
were also intravenous drug users.
bANCA data was obtained in 43/49 patients (88%), although testing was only
carried out in 29/43 patients.
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Bartonella, Coxiella, Cardiobacterium, or Gemella had
crescentic GN, and 3/4 cases of culture-negative
endocarditis had crescentic GN. Eighty-two percent of
patients had community-acquired IE in native valves, 92%
of which had positive blood cultures versus 89% positive in
patients with prosthetic valves.
Renal pathology
Histologic findings are summarized in Table 3 and illustrated
in Figures 1–3. Light microscopy (LM) samples had a mean
of 15 glomeruli (range 2–43). Global sclerosis varied from 0
to 16, with a median of only 1. Overall, crescentic GN was the
most common pattern seen in our series (26/49, 53%). In a
majority of patients, the glomerular inflammatory changes
were diffuse (16/26, 62%), and most patients also had focal
necrotizing lesions (20/26, 77%). Necrotizing areas were not
seen in biopsies without crescents. By definition, glomeruli
and portions of the glomerular tufts uninvolved by necrosis
or crescent formation in this group did not show proliferative
changes.
Diffuse proliferative GN was the second most common
pattern (16/49, 33%) (Table 3 and Figure 1). Only two cases
had the classically described pattern of focal proliferative GN
without crescents or necrosis (4%) (Figure 1). Of the 18 total
patients with proliferative GN, seven also had focal crescent
formation.
Mild mesangial hypercellularity was the third major find-
ing after crescentic and proliferative GN, and it accounted for
5/49 cases (10%) (Table 3). All of these cases showed only
mild focal and segmental mesangial hypercellularity without
endocapillary proliferation or crescent formation (Figure 1).
Table 2 | Cardiac and bacterial characteristics
n (%)
Valve/locationa
Tricuspid 18 (43)
Mitral 14 (33)
Aortic 12 (29)
Pulmonic 2 (5)
Chordae tendinae 1 (2)
Culture results
Positive 44 (90)
Negativeb 4 (8)
Unknown 1 (2)
Bacterial agentc
Staphylococcus 25 (53)
Streptococcus 11 (23)
Bartonella henselaeb 4 (8)
Coxiella burnetii 2 (4)
Cardiobacterium hominis 1 (2)
Gemella 1 (2)
Location
Agent
Tricuspid
(%)
Mitral
(%)
Aortic
(%)
Pulmonic
(%)
Chordae
(%)
Staphylococcus 76 31 50 50 0
Streptococcus 12 46 17 0 0
Otherd 12 23 33 50 100
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MRSS, methicillin-
sensitive Staphylococcus aureus.
aTwo patients had aortic and mitral valve involvement, two had tricuspid and
mitral valve involvement, and one had tricuspid and pulmonic valve involvement.
bThree patients had blood culture positive for Bartonella, and one patient with
negative blood cultures showed serologic evidence of active Bartonella infection.
cMRSA, n¼ 14; MRSS, n¼ 9; Staphylococcus not further classified as methicillin-
sensitive or methicillin-resistant, n¼ 2; Streptococcus viridans, n¼ 3; Streptococcus
agalactiae, n¼ 1; Streptococcus mitis, n¼ 1; Streptococcus sanguinis, n¼ 1;
Enterococcus faecalis, n¼ 3; Streptococcus not further specified, n¼ 2; culture result
was unavailable in two cases.
dOther includes Bartonella henselae, Coxiella, Cardiobacterium hominis, Gemella, and
culture-negative cases.
Table 3 | Pathologic features
Mean
(range)
Light microscopy
Total glomeruli 15 (2–43)
Sclerotic glomeruli 2 (0–16),
11%
(0–87%)
n (%)
Glomerular pattern
Crescentic 26 (53)
Focal 10 (20)
Diffuse 16 (33)
Necrotizing foci 20 of 26
(77)
Proliferative 18 (37)
Focal 2 (4)
Diffuse 16 (33)
Mesangial
proliferative
5 (10)
Immunofluorescence microscopy
Staining pattern
Negative 3 (6)
Mesangial alone 20 (41)
Capillary wall
alone
2 (4)
Capillary wall
and mesangial
24 (49)
Immunoreactant IgG IgM IgA C3
n (%) 13 (27%) 18 (37) 14 (29) 46 (94)
C3 only or C3þ single Ig C3þ IgG C3þ IgM C3þ IgA C3 Only
n (%) 2 (4%) 8 (16%) 3 (6%) 18 (37)
Combined Igs IgG IgM IgG IgA IgM IgA IgG IgM IgA
n (%) 3 (6%) 6 (12%) 3 (6%) 2 (4)
Negative for all Negative
n (%) 3 (6)
n (%)
Electron microscopy
Mesangial deposits 41 (84)
Subendothelial deposits 22 (45)
Subepithelial deposits 17 (35)
Subepithelial ‘humps’ 7 (14)
No deposits 5 (10)
Abbreviations: C3, complement component 3; Ig, immunoglobulin.
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No other forms of GN were identified. Specifically, no cases
of membranoproliferative GN with or without cryoglobulinemic
features or cases of thrombotic microangiopathy were found.
Acute tubular injury was present in the majority of cases
(86%). Histological red blood cell casts were noted in more
than half of the cases (64%). Almost all cases (88%) had
interstitial inflammation, which was most often focal (64%),
but abundant interstitial neutrophils were present in only
seven cases (14%). No examples of eosinophilic allergic
interstitial nephritis were seen. No micro-abscesses or cortical
a b
c d
e f
Figure 1 | Light microscopy findings in endocarditis-associated glomerulonephritis. (a) Cellular crescents with necrotizing foci (Jones
methenamine silver; original magnification  400). (b) Segmental cellular crescent with no underlying proliferation (periodic acid–Schiff; original
magnification  400). (c) Diffuse crescentic glomerulonephritis (Jones methenamine silver; original magnification  400). (d) Acute focal
proliferative glomerulonephritis (hematoxylin and eosin; original magnification  400). (e) Diffuse proliferative glomerulonephritis (periodic
acid–Schiff; original magnification  400). (f) Mesangial proliferative glomerulonephritis (periodic acid–Schiff; original magnification  400).
a b
Figure 2 | Immunofluorescence microscopy findings in endocarditis-associated glomerulonephritis. (a) Glomerulus with predominantly
mesangial staining by C3 (fluorescein-conjugated anti-human C3; original magnification  400). (b) Glomerulus with mesangial and capillary
wall reaction with C3 (fluorescein-conjugated anti-human C3; original magnification  400).
1244 Kidney International (2015) 87, 1241–1249
c l in i ca l inves t iga t ion CL Boils et al.: Endocarditis-associated glomerulonephritis
necrosis were present. The degree of tubular atrophy and
interstitial fibrosis present was most often mild (43%) or
absent (37%). Moderate chronic change was present in 16%
of the cases, and severe chronic change was present in 4% of
the cases. Similarly, arteriosclerosis and arteriolar hyalinosis
were most often absent (39%) or mild (31%). Moderate
vascular disease was seen in 27%, with severe vascular disease
in only two cases (4%). No histologic evidence of extra-
glomerular vasculitis was seen.
The immunofluorescence (IF) findings are presented in
Tables 3 and 4, and illustrated in Figure 2. Overall, C3 was
present in 94% of cases, whereas IgM was found in 37%, IgA
in 29% and IgG in 27% of cases. Six cases had IgA-dominant
staining and an additional two were codominant for IgA
and IgG. Three patients had no significant deposition of
immunoglobulin or C3. Twenty-two patients (44%) met the
criteria for pauci-immune IF staining,16 of whom 11 patients
had crescentic GN by LM. Of these 11 patients, ANCA was
positive in 3, negative in 4, and not done in 4. Of interest, only
50% of cases with a proliferative pattern by LM had positive
IgG, and biopsies with a crescentic pattern had IgG in only
15% of cases. In some cases, staining was positive for more
than one immunoglobulin, but a ‘full house’ pattern with IgG,
IgM, and IgA positivity was seen in only two cases (Table 4). C3
was positive in all cases in which immunoglobulins were found.
C3-only staining was present in 18 (37%) cases. Although there
was no statistical difference between the occurrence of
staphylococcal or streptococcal species in blood cultures
between the pauci-immune cases and those with IC deposition,
all cases with Bartonella, Coxiella, Cardiobacterium, or Gemella
had immunoglobulin and C3 deposition.
The presence and location of deposits by electron
microscopy (EM) is detailed in Table 3 and shown in
Figure 3. Deposits were present in 44/49 cases (90%). Only
seven (14%) showed classic infection-related subepithelial
hump–like deposits. Of these seven cases, five were diffuse
proliferative and two showed mesangial proliferation, the latter
with only C3 deposits. Subendothelial deposits were found in
45% of biopsies. The most common site for deposits was the
mesangial area (84%). The degree of foot process effacement
was variable, with approximately equal proportions of none
plus mild (45%) and moderate plus severe (55%).
Treatment
Treatment data was obtained in 86% of patients, and is
presented in Table 5. Treatments used consisted of antibiotics in
28/42 patients (67%) and antibiotics plus immunosuppressive
therapy in 14/42 (33%). Specifically, immunosuppressive
treatments used in the 14 patients included prednisone/
methylprednisone in 10 patients, Cytoxan in 1 patient, and
both prednisone/Cytoxan in 3 patients. One of the patients
treated with antibiotics plus prednisone received plasma
exchange. Eight patients (19%) were treated surgically,
including 6 with valve replacement and 2 with valve repair.
Follow-up and outcomes
Follow-up outcome was available in 78% of patients, with an
average follow-up term of 25 months (range 0.5–84 months).
Patient characteristics and biopsy findings related to outcome
1 µm 1 µm
a b
Figure 3 | Electron microscopy findings in endocarditis-associated glomerulonephritis. (a) Mesangial electron-dense deposits (arrow) in
diffuse crescentic glomerulonephritis (original magnification 12,000). (b) Subendothelial electron-dense deposits (arrow) in focal proliferative
glomerulonephritis (original magnification 12,000).
Table 4 | Immunofluorescence findings by light microscopy
pattern
Crescentic
(n¼ 26), n
(%)
Acute prolif-
erative
(n¼ 18), n (%)
Mesangial
proliferative
(n¼ 5), n (%)
Staining pattern
None 2 (8) 0 1 (20)
Mesangial-only 13 (50) 3 (17) 4 (80)
Capillary wall and
mesangium
11 (42) 13 (72) 0
Capillary wall-only 0 2 (11) 0
% Positive
(mean in-
tensity)
% Positive
(mean inten-
sity)
% Positive
(mean in-
tensity)
Immunoreactant
IgG 15 (1.8) 50 (1.9) 0
IgM 58 (2.1) 17 (1.7) 0
IgA 12 (1.7) 61 (2.3) 0
C3 92 (2.5) 100 (2.8) 100 (2.8)
n (%) n (%) n (%)
Pauci-immune 11 (42) 6 (33) 5 (100)
Abbreviations: C3, complement component 3; Ig, immunoglobulin.
Kidney International (2015) 87, 1241–1249 1245
CL Boils et al.: Endocarditis-associated glomerulonephritis c l i n i ca l inves t iga t ion
are presented in Table 5. Of the 38 patients with follow-up,
eight died (21%); of the surviving patients, 4 progressed to
end-stage renal disease (10%), 14 had persistent renal
dysfunction (37%), and 12 had complete renal recovery (32%).
The eight patients who died included the 3-year-old and
seven adults (age range 47–79, mean 64 years). Three of these
patients had a prosthetic cardiac valve. All patients who died
had fevers and vegetations by echocardiogram, as well as a
combination of various other clinical findings. The organ-
isms on culture included one patient each with Coxilla
burnetii, Gemella species, and Bartonella, with the remainder
staphylococcal species. Half of the patients were treated with
antibiotics and half of them were treated with antibiotics and
steroids, including one with Cytoxan. None were treated
surgically.
Of the eight deaths, four deaths occurred within 2 months
of biopsy: one died 3 days after biopsy owing to sepsis, one
remained on hemodialysis for 1.5 months and died owing to
disseminated intravascular coagulation, one died owing to
cerebral hemorrhage 1 month after biopsy, and another died
1.5 months after biopsy from endocarditis/pulmonary
hemorrhage. The four patients with later deaths included
one with persistent renal dysfunction and then death 90
months later of unknown cause, and three with end-stage
renal disease and deaths occurring 18, 23, and 78 months
after the biopsy.
Table 5 | Patient characteristics and biopsy findings as related to outcome
Death End-stage renal disease Persistent renal dysfunction Complete recovery
No. of patients, n (% out of 38 with follow-up) 8 (21) 4 (10) 14 (37) 12 (32)
Gender/age
Male:female, n/n 7/1 2/2 12/2 7/5
Age (years), mean (range) 57 (3–79) 56 (48–66) 50 (16–84) 45 (31–)
Average creatinine (range)
At biopsy 2.6 (1.0–4.7) 5.6 (3.4–6.7) 3.6 (2.6–5.8) 3.6 (1.0–7.0)
At follow-up 4.0a (1.7–7.6) n/ab 2.0 (1.2–3.1) 1.0 (0.8–1.3)
ANCA
Unknown/not done 0/2 1/2 0/4 0/4
Positive 1 0 5 1
Negative 5 1 5 7
Agent on culture, n (%)
Staphylococcus 4 (50) 3 (75) 4 (28) 8 (66)
Streptococcus 0 1 (25) 5 (36) 2 (17)
Otherc 4 (50) 0 5 (36) 2 (17)
Pattern of glomerular injury, n (%)
Mesangial proliferative 0 1 (25) 2 (14) 0
Diffuse proliferative 1 (13) 2 (50) 4 (29) 7 (58)
Focal crescentic 3 (37) 0 3 (21) 2 (17)
Diffuse crescentic 4 (50) 1 (25) 5 (36) 3 (25)
Other renal biopsy findings
% Of globally sclerotic glomeruli, average n (range) 7 (0–29) 17 (8–28) 14 (0–53) 5 (0–18)
Interstitial fibrosis, n (%)
None or mild 7 (88) 1 (25) 11 (79) 11 (92)
Moderate 1 (12) 3 (75) 2 (14) 1 (8)
Severe 0 0 1 (7) 0
Acute tubular injury, n (%) 7 (88) 3 (75) 12 (86) 8 (67)
Interstitial inflammation, n (%)
None or focal 5 (63) 3 (75) 11 (79) 9 (75)
Diffuse 3 (37) 1 (25) 3 (21) 3 (25)
Immune deposition, n (%)
Negative 0 1 (25) 0 1 (9)
C3 only 4 (50) 3 (75) 9 (64) 4 (33)
C3 and immunoglobulin(s) 4 (50) 0 5 (36) 7 (58)
Treatment, n (%)
Antibiotics 4 (50) 3 (75) 8 (57) 8 (67)
Antibiotics and immunosuppression 4 (50) 1 (25) 6 (43) 4 (33)
Valve replacement or repair 0 1 (25) 4 (29) 3 (25)
Abbreviations: ANCA, anti-neutrophil cytoplasmic antibody; C3, complement component 3; Cr, creatinine.
aExcluding follow-up of Cr values from patients on hemodialysis at the time of follow-up/death;
bPatients on hemodialysis at the time of follow-up.
cOther includes Bartonella henselae, Coxiella, Cardiobacterium hominis, Gemella and culture-negative cases.
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There were no clinicopathologic trends useful in differ-
entiating the patients who died from surviving patients
(Table 5). In comparison of renal biopsy findings among
surviving patients, those with higher percentages of globally
sclerotic glomeruli and more interstitial fibrosis had worst
outcomes. The group that progressed to end-stage renal
disease had a higher average serum creatinine at biopsy (5.6),
compared with both groups with persistent renal dysfunction
and complete recovery (3.6).
DISCUSSION
Our study provides data from the current era (2001–11) on
the clinical and pathologic features of IE-related GN in 49
patients who underwent renal biopsies during the active
phase of their illnesses, and represents the largest study of this
entity with both clinical and complete renal biopsy data
available.
In keeping with the overall trends in infection-related GN,
our findings in IE in this predominately adult series include a
3.5:1 male predominance, older mean age (48 years) with
over 30% elderly patients, increased prevalence of staphylo-
coccal rather than streptococcal infection, and the disease was
usually ongoing at the time of biopsy rather than being
postinfectious such that the finding of GN prompted
investigations that led to a diagnosis of IE. The observation
that the most common presentation was acute renal failure
rather than nephritic syndrome differs from overall findings
in infection-related GN7 and may be unique to this patient
population with compromised cardiac function.
The biopsy findings in our study also differ from many of
those previously reported. Both renal medicine and patho-
logy textbooks17–22 report that more than 80% of cases of IE
with GN have a focal, segmental, or diffuse proliferative GN
with endocapillary proliferation and occasional infiltrating
leukocytes. These descriptions are based primarily on autopsy
studies often from the pre-antibiotic era. In contrast, we
found crescentic GN to be the most common finding, with
over 50% of patients exhibiting extensive crescent formation
and a majority having diffuse rather than focal pattern of
injury. Crescentic GN has been previously described in IE,
primarily in case reports. Kannan and Mattoo23 identified 11
cases described before 2000 but identified crescents as a rare
finding. However, Neugarten and Baldwin6 reported focal or
diffuse proliferative GN in 22% of biopsied and autopsied
patients with IE, of whom 50% had crescents in glomeruli,
and Majumdar et al.13 identified 16 cases of GN out of 62 IE
patients studied by biopsy (20) or autopsy (42), of whom
11 had crescents. Our findings in a larger cohort studied
exclusively by renal biopsy suggest a similar predominance
of crescentic lesions, an observation that differs from the
findings in typical infection-related GN where proliferative
lesions predominate and extensive crescents are seen in only
5% of cases.7
The immunopathology of IE GN has not been well
characterized beyond identification of IgG and C3 deposition
in an IC pattern.13,24–27 Our findings suggest that more
complex pathogenetic mechanisms are involved. Although
C3 staining was positive in virtually the entire cohort,
staining for IgG was present in only 27% and in fewer than
15% of those with the most severe crescentic lesions. A lack of
immunoglobulin staining in crescentic, or vasculitic, IE-
associated GN has also been noted previously.13 The finding
of prominent C3 staining and the presence of readily
detectable immune deposits by EM are more consistent
with the C3-dominant pattern of immune deposition
commonly seen in infection-related GN in general7 than
with typical findings in either IC disease or ‘pauci-immune’
ANCA-associated vasculitis. However, some C3 deposition
can also be seen in ANCA-associated vasculitis.28–30
Our findings raise several questions regarding the
pathogenesis of the GN in patients with IE. Although
initially believed to be embolic in nature, an underlying IC
pathogenesis has been assumed for years based on findings of
granular IgG and C3 deposits by IF.24–27 Our findings support
a primary IC mechanism in only a minority of patients
(27%), a conclusion also reached by others.13 When
glomerular IC formation does occur, it could result from
passive trapping of ICs from the circulation, from the
formation of ICs in situ following prior localization of
exogenous cationic bacterial antigens, or from reactivity of
IgG antibody with endogenous components of the
glomerulus itself, as occurs in membranous nephropathy or
anti-glomerular basement membrane disease.31 In the latter
case, molecular mimicry between bacterial and glomerular
constituents would likely be involved, making the process
autoimmune in nature.8 However, our findings, including the
paucity of IgG deposition in severe cases and the probable
alternate pathway mechanism of complement activation,
suggest that in a majority of cases IC formation in glomeruli
is not the principal pathogenic event.
Several alternative mechanisms could explain how glome-
rular injury occurs in IE without IgG deposition. Some
bacterial antigens, for example, the streptococcal pyogenic
exotoxin B antigen incriminated in poststreptococcal GN,
can localize in glomeruli independently of antibody, causing
injury through activation of the plasmin system and direct
activation of the alternate complement pathway via man-
nose-binding lectin, thus producing a C3-dominant nephro-
pathy.8,32 Staphylococcal super-antigens are also capable of
causing direct tissue injury, especially to endothelial cells, in
the absence of immune deposits.33 No studies of localization
or biologic activity of bacterial antigenic proteins in IE have
yet been performed. Another potential mechanism could be
the associated ANCA antibody (28%), a finding also reported
by others.34,35 Bacterial infections are well known to lead to
ANCA-positive serology including suppurative lung disease,
and infections with Pseudomonas, Klebsiella, E. coli, and Ross
River virus.28,36–38 Infectious agents such as Staphylococci can
induce antibodies to complementary peptides of the target
antigen (autoantigen complementarity), leading to anti-
idiotypic antibodies that react with self-proteins such as
proteinase-3 to produce autoimmune tissue injury without
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depositing in glomeruli.39 If ANCA antibodies are pathogenic
rather than secondary phenomena in these patients, they are
currently believed to damage glomeruli indirectly by
activating neutrophils in the microvasculature that release
complement-activating factors leading to alternative pathway
activation involving the C5a receptor.36,37,40 Finally, the recent
explosion of interest in nephropathies with a dominance of
C3 deposition has clarified the role of inherited and acquired
abnormalities in complement-regulatory proteins such as
complement factor H in contributing to unregulated
activation of the alternative complement pathway leading to
deposition of complement proteins in glomeruli and GN in
diseases such as dense deposit disease.41 Initiation of com-
plement activation by infections in the presence of inherited
or acquired abnormalities in complement regulation has been
documented to lead to persistent, chronic C3 nephropathies
with similar pathologic appearances to many of the IE
patients reported here.42 Thus, some of the lesions seen in IE-
related GN could reflect complement regulatory protein
dysfunction.
The findings in this study update and expand current
understanding of both the clinical and pathologic spectrum
of GN in IE and add to the knowledge of infection-related
GN in general. Appreciation of both the clinical and
pathologic manifestations of IE GN in the current era,
including the frequency of AKI and of crescentic GN, should
contribute to earlier diagnosis and more effective treatment.
In one series, IE was unrecognized in almost 20% of cases at
the time of nephrology consult,13 and in another series it was
not recognized until autopsy in 38% of cases.5 These
observations suggest that the immunologic mechanisms
that underlie GN in patients with IE are more complex
than previously appreciated.
MATERIALS AND METHODS
By retrospective review, 49 patients with a clinical diagnosis of IE
that fulfilled the modified Duke criteria43 who underwent native
renal biopsy between 2001 and 2011 were identified at Mayo Clinic,
Rochester (18), and at Nephropath, Little Rock (31). These biopsies
were received from multiple medical centers across the United
States, with various nephrology practice settings represented.
All 49 biopsies were processed by standard techniques for LM, IF,
and EM.44–46 Briefly, LM samples were fixed in formalin, processed
into paraffin, cut at 3mm, and stained with hematoxylin and eosin,
Jones methenamine silver, Masson trichrome, and periodic
acid–Schiff reagent. IF sections were snap-frozen, cut at 4–5mm in
a cryostat, and reacted with fluorescein-tagged polyclonal rabbit anti-
human antibodies to IgG, IgA, IgM, C3, C1q, fibrinogen, and k- and
l-light chains (Dako, Carpenteria, CA) for 1 h; next, they were rinsed
and a coverslip was placed using aqueous mounting medium. IF
intensity was scored on a 0–3þ scale. Samples for EM were
processed into plastic and thin sections were made, and electron
photomicrographs were routinely taken at 4000, 12,000, and
20,000.
Clinical data including demographic information, medical
history, presenting clinical and laboratory findings, endocarditis
valve involvement, culture data, treatment, and follow-up data were
obtained from the patient’s medical record/treating physicians. The
following clinical definitions were applied: acute renal failure—
doubling of the serum creatinine; chronic renal failure—progressive
decline in glomerular filtration rate over months; rapidly progressive
renal failure—renal failure developing over weeks to months; acute
nephritic syndrome—red blood cell casts, hematuria, hypertension,
and renal failure; nephrotic syndrome—nephrotic range proteinuria
(43.5 g per day) with hypoalbuminemia (serum albumin o3 g
per dl) and peripheral edema; isolated hematuria—Z5 red
blood cells per high power field in the urinary sediment.
Quantification of proteinuria was performed by 24-h urine collec-
tion or by spot urine protein to creatinine ratio when quantification
was not available.
Biopsies were designated as having one of five patterns of
glomerular injury: mesangial proliferative, focal necrotizing and
crescentic, diffuse necrotizing and crescentic, focal proliferative, or
diffuse proliferative. Glomeruli with an increase in mesangial matrix
and cells without closure of capillary lumens were included in the
mesangial proliferative group. Designation as focal versus diffuse
was made by applying a cutoff value of 50%, with focal o50% of
intact glomeruli involved and diffuse Z50% of intact glomeruli
involved.47 Proliferation in biopsies with focal or diffuse
proliferative patterns was defined as endocapillary hypercellularity
and occlusion of capillary lumens by endothelial cells, mesangial
cells, and/or white blood cells from circulation. Proliferation in
biopsies with the mesangial proliferative pattern of glomerular
injury was defined as Z4 cells per mesangial region in more than
50% of glomeruli without occlusion of capillary loops.48 Biopsies in
the crescentic pattern of injury showed cellular proliferation within
Bowman’s space, with or without necrosis of the glomerular tuft,
without endocapillary hypercellularity. Interstitial fibrosis was
defined by the percentage of cortical involvement: mild, o25%;
moderate, 25–50%; and severe, 450%.
IF was given a score of 0 if negative, and a score of 1, 2, or 3þ
for positive staining with increasing levels of intensity. Pauci-
immune was defined as 0–2þ intensity for immunoglobulins (IgG,
IgM, and IgA). This cutoff was based on the definition provided by
Jennette et al.16 as 2þ or less staining for immunoglobulins on a
scale of 0 to 4þ . Of note, as the definition of pauci-immune disease
is defined by immunoglobulin staining only, we did not use an
intensity cutoff for complement staining in glomeruli. This also
seems prudent given that large case series have shown that
glomerular C3 deposition is not uncommon in pauci-immune,
ANCA-associated GN.29,30
For outcome analysis, end-stage renal disease was defined as
requiring renal replacement therapy, persistent renal dysfunction
was defined by elevation of serum creatinine 0.2mg/dl above
baseline levels or follow-up creatinine 41.2mg/dl (for those in
whom baseline levels were unavailable), and complete recovery was
defined as normalization of serum creatinine to baseline levels or to
creatinine r1.2mg/dl (for those patients in whom baseline
creatinine values were unavailable).
The Institutional Review Board of the Mayo Clinic Foundation
and, for Nephropath, the Institutional Review Board of Schulman
Associates approved this study.
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